David J. Valacer

636 total citations
15 papers, 485 citations indexed

About

David J. Valacer is a scholar working on Immunology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David J. Valacer has authored 15 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David J. Valacer's work include Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory and Cough-Related Research (3 papers). David J. Valacer is often cited by papers focused on Asthma and respiratory diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory and Cough-Related Research (3 papers). David J. Valacer collaborates with scholars based in United States. David J. Valacer's co-authors include David R. Mink, Stephen P. Peters, Craig A. Jones, Tmirah Haselkorn, Scott T. Weiss, Vincent R. Bonagura, Mary DiMaio, Mary Reich Cooper, Norman T. Ilowite and Donald G. Payan and has published in prestigious journals such as Blood, PEDIATRICS and Annals of the New York Academy of Sciences.

In The Last Decade

David J. Valacer

15 papers receiving 466 citations

Peers

David J. Valacer

PHYSI

PRM

IMMUN

GHP

BL Barber United States

Eve Denton Australia

Manuel Soto-Quirós Costa Rica

Eva Martínez-Moragón Spain

Petra LeBeau United States

Jan Holt Norway

Leonard Fromer United States

Ian Johnston United Kingdom

James Herman United States

A. Forget Canada

BL Barber United States

David J. Valacer

279 ×0.9

PHYSI

268 ×1.0

PRM

22 ×0.3

IMMUN

59 ×1.3

24 ×0.6

GHP

Citations per year, relative to David J. Valacer David J. Valacer (= 1×) peers BL Barber

Countries citing papers authored by David J. Valacer

Since Specialization

Citations

This map shows the geographic impact of David J. Valacer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Valacer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Valacer more than expected).

Fields of papers citing papers by David J. Valacer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Valacer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Valacer. The network helps show where David J. Valacer may publish in the future.

Co-authorship network of co-authors of David J. Valacer

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Valacer. A scholar is included among the top collaborators of David J. Valacer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Valacer. David J. Valacer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hamlin, Paul A., Michelle A. Fanale, Steven I. Park, et al.. (2016). Data from the First CD20-Targeted Immunotoxin, MT-3724, in a Phase I/Ib Study in Relapsed/Refractory (R/R) Non-Hodgkin's B-Cell Lymphoma (NHL). Blood. 128(22). 4200–4200. 3 indexed citations

Hamlin, Paul A., Catherine Diefenbach, David J. Valacer, Jack P. Higgins, & Michelle A. Fanale. (2015). Phase I/Ib Study of the Novel Immunotoxin MT-3724 in Relapsed/Refractory Non-Hodgkin's B-Cell Lymphoma (NHL). Blood. 126(23). 5112–5112. 1 indexed citations

Peters, Stephen P., Craig A. Jones, Tmirah Haselkorn, et al.. (2007). Real-world Evaluation of Asthma Control and Treatment (REACT): Findings from a national Web-based survey. Journal of Allergy and Clinical Immunology. 119(6). 1454–1461. 202 indexed citations

Valacer, David J., et al.. (2001). Impact of a pediatric asthma clinical pathway on hospital cost and length of stay*. Pediatric Pulmonology. 32(3). 211–216. 73 indexed citations

Valacer, David J.. (2000). Childhood Asthma. Drugs. 59(Supplement 1). 1–8. 5 indexed citations

Kishiyama, Jeffrey L., David J. Valacer, Charlotte Cunningham‐Rundles, et al.. (1999). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma. Clinical Immunology. 91(2). 126–133. 51 indexed citations

Millar, Johnny, et al.. (1997). Idiopathic bronchocentric granulomatosis in an adolescent. Pediatric Pulmonology. 23(1). 62–65. 2 indexed citations

Cunningham–Rundles, Susanna, et al.. (1994). New Perspectives on Use of Thymic Factors in Immune Deficiencya. Annals of the New York Academy of Sciences. 730(1). 71–83. 1 indexed citations

Bonagura, Vincent R., et al.. (1994). Aminophylline Therapy Does Not Improve Outcome and Increases Adverse Effects in Children Hospitalized With Acute Asthmatic Exacerbations. PEDIATRICS. 93(2). 205–210. 61 indexed citations

10.

Valacer, David J., et al.. (1991). Identification of anti-idiotypic antibodies in the sera of ryegrass-allergic and nonallergic individuals. Journal of Allergy and Clinical Immunology. 88(3). 349–355. 9 indexed citations

11.

Bonagura, Vincent R., Norman T. Ilowite, Lynda Hatam, David J. Valacer, & Josiah F. Wedgwood. (1991). Expression of the major rheumatoid factor cross-reactive idiotype in pediatric patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology. 60(2). 232–243. 3 indexed citations

12.

Bonagura, Vincent R., Ben Z. Katz, David J. Valacer, et al.. (1990). Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA + T-cell lymphoma containing linear, EBV DNA. Clinical Immunology and Immunopathology. 57(1). 32–44. 32 indexed citations

13.

Bonagura, Vincent R., et al.. (1989). Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous γ-globulin therapy, and natural killer deficiency. Clinical Immunology and Immunopathology. 51(2). 216–231. 22 indexed citations

14.

Ilowite, Norman T., et al.. (1988). Detection of the major rheumatoid factor cross-reactive idiotype precedes human IgG binding activity in a patient with polyarticular juvenile rheumatoid arthritis.. PubMed. 15(12). 1789–92. 2 indexed citations

15.

Goetzl, E J, David J. Valacer, Donald G. Payan, & Michael Y. Wong. (1986). Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. Journal of Allergy and Clinical Immunology. 77(5). 693–698. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact